Pharmaceutical companies and regulators are concealing adverse drug event data to protect market share and revenue streams.

The claim that pharmaceutical companies and regulators are concealing adverse drug event data to protect market share and revenue streams is a serious accusation. According to the FDA, pharmaceutical companies are legally required to report adverse events, and failure to do so can result in fines and recalls FDA. However, there have been instances where companies have been accused of not reporting such data, which can lead to regulatory scrutiny and legal consequences Combies Hanson. While there are mechanisms in place to ensure transparency, the effectiveness of these systems can vary, and some companies may attempt to bypass regulations, but this is not a widespread or accepted practice.